147 related articles for article (PubMed ID: 37253400)
1. A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus.
Zhou Z; Li C; Tan Z; Sun G; Peng B; Ren T; He J; Wang Y; Sun Y; Wang F; Li W
Antiviral Res; 2023 Aug; 216():105642. PubMed ID: 37253400
[TBL] [Abstract][Full Text] [Related]
2. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia.
Wu M; Wang C; Shi B; Fang Z; Qin B; Zhou X; Zhang X; Yuan Z
Antiviral Res; 2020 Aug; 180():104826. PubMed ID: 32502604
[TBL] [Abstract][Full Text] [Related]
3. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
[TBL] [Abstract][Full Text] [Related]
4. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.
Qi Z; Li G; Hu H; Yang C; Zhang X; Leng Q; Xie Y; Yu D; Zhang X; Gao Y; Lan K; Deng Q
J Virol; 2014 Jul; 88(14):8045-56. PubMed ID: 24807718
[TBL] [Abstract][Full Text] [Related]
5. Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model.
Li G; Zhu Y; Shao D; Chang H; Zhang X; Zhou D; Gao Y; Lan K; Deng Q
Hepatology; 2018 Jan; 67(1):56-70. PubMed ID: 28749559
[TBL] [Abstract][Full Text] [Related]
6. Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection.
Kruse RL; Legras X; Barzi M
Virus Res; 2021 Jan; 292():198224. PubMed ID: 33166564
[TBL] [Abstract][Full Text] [Related]
7. Illuminating the Live-Cell Dynamics of Hepatitis B Virus Covalently Closed Circular DNA Using the CRISPR-Tag System.
Ding J; Yi Z; Zai W; Wu M; Chen B; Cai Q; Zhang X; Yuan Z
mBio; 2023 Apr; 14(2):e0355022. PubMed ID: 36840581
[TBL] [Abstract][Full Text] [Related]
8. A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome.
Kruse RL; Barzi M; Legras X; Pankowicz FP; Furey N; Liao L; Xu J; Bissig-Choisat B; Slagle BL; Bissig KD
JHEP Rep; 2021 Apr; 3(2):100252. PubMed ID: 33733079
[TBL] [Abstract][Full Text] [Related]
9. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-33 mediates both immune-related and non-immune-related inhibitory effects against hepatitis B virus.
Gao Z; Shen Z; Wu J; Song Y; Liu N; Deng Q; Xie Y; Liu J
Antiviral Res; 2022 Oct; 206():105404. PubMed ID: 36049553
[TBL] [Abstract][Full Text] [Related]
11. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
[TBL] [Abstract][Full Text] [Related]
12. HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage.
Wang Y; Li Y; Zai W; Hu K; Zhu Y; Deng Q; Wu M; Li Y; Chen J; Yuan Z
Hepatology; 2022 May; 75(5):1275-1288. PubMed ID: 34779008
[TBL] [Abstract][Full Text] [Related]
13. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
[TBL] [Abstract][Full Text] [Related]
14. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
[TBL] [Abstract][Full Text] [Related]
15. The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.
Guo X; Chen P; Hou X; Xu W; Wang D; Wang TY; Zhang L; Zheng G; Gao ZL; He CY; Zhou B; Chen ZY
Sci Rep; 2016 May; 6():25552. PubMed ID: 27174254
[TBL] [Abstract][Full Text] [Related]
16. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.
Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y
Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514
[TBL] [Abstract][Full Text] [Related]
17. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
[TBL] [Abstract][Full Text] [Related]
18. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
[TBL] [Abstract][Full Text] [Related]
19. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
[TBL] [Abstract][Full Text] [Related]
20. Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.
Ko C; Su J; Festag J; Bester R; Kosinska AD; Protzer U
Antiviral Res; 2021 Oct; 194():105140. PubMed ID: 34284057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
